Supported by

Asabys Partners is a venture capital firm from Barcelona investing across the board in human healthcare. We are active in the health-tech and biopharma industries and aim to invest in Spain and abroad in highly innovative and transformative technologies. We are motivated by the idea of pushing the boundaries of science and medicine. We do this through the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry. We have an entrepreneurial spirit and seek to be involved in the building and management of our companies. Not just investors, we consider ourselves as partners and collaborators to our portfolio companies.

Asabys started operations in 2019 and is currently fundraising its first fund, Sabadell Asabys Health Innovation Investments, with a target size of €70M, with the participation of Banc Sabadell as anchor investor in their strategy to promote the healthcare innovation entrepreneurial ecosystem. Investments will be spread between biopharma and health-tech, allowing us to hedge our risks and seek high returns for our investors. We are highly experienced professionals with a solid track record of contributing our experience and network to board of directors. We bring our capabilities and experience in building and selling businesses to major corporations of the healthcare industry.

We are indication agnostics and will consider investing in any segment of our targeted industries, provided the investment proposal presents an outstanding scientific quality, a clear medical rationale, and a solid business and investment case.

Do you have a big idea?

Contact Us